Stocks/TCRX

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

TCRX

↓ PDF (Pro)
TScan Therapeutics Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$1.21
+0.00%today
MKT CAP
$73M
+17.5% · 1Y
Earnings History
+6.3%
+13.4%
+15.6%
+34.8%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$1.21
Low
$5.00
Analyst Mean
$6.00
High
$7.00
4 analystsNone
Full Financials
Trailing P/E-
Forward P/E-1.5x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+2.2%
5y Revenue CAGR-8.6%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.2%
Institutional Ownership60.2%
Short % of Float2.39%
Days to Cover0.9d
1 Week-4.0%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
LYNX1 CAPITAL MANAGEMENT LPBeneficial Owner of more than 10% of a Class of SecurityBuy161,801$0.90$0.15M2025-12-23
LYNX1 CAPITAL MANAGEMENT LPBeneficial Owner of more than 10% of a Class of SecurityBuy2,588,794$1.20$3.11M2025-05-20
LYNX1 CAPITAL MANAGEMENT LPBeneficial Owner of more than 10% of a Class of SecurityBuy131,800$2.90$0.39M2024-12-13
LYNX1 CAPITAL MANAGEMENT LPBeneficial Owner of more than 10% of a Class of SecurityBuy947$4.34$0.00M2024-11-15
KLENCKE BARBARA M.D.DirectorBuy5,000$5.29$0.03M2024-09-23
Top Holders
HolderType% HeldValueΔ SharesAs of
Lynx1 Capital Management Lpinstitution14.36%$0.01B+0.00%2026-03-31
BVF Inc.institution9.36%$0.01B+0.00%2025-12-31
Baker Bros. Advisors, LPinstitution4.99%$0.00B+0.00%2025-12-31
Vanguard Group Incinstitution4.43%$0.00B+6.81%2025-12-31
Blackrock Inc.institution3.31%$0.00B-22.41%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.69%$0.00B+10.68%2025-12-31
Deer Management Co. LLCinstitution2.23%$0.00B+0.00%2025-12-31
Renaissance Technologies, LLCinstitution2.04%$0.00B+37.49%2025-12-31
abrdn Life Sciences Investorsfund1.69%$0.00B+22.97%2025-12-31
Aberdeen Group plcinstitution1.64%$0.00B-48.58%2026-03-31
abrdn Healthcare Investorsfund1.51%$0.00B+64.11%2025-12-31
Two Sigma Investments, LPinstitution1.17%$0.00B+55.26%2025-12-31
DC Funds, LPinstitution1.13%$0.00B+0.00%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund1.03%$0.00B+0.00%2025-12-31
BlackRock Funds-BlackRock Health Sciences Opportunities Portfoliofund1.00%$0.00B-2.12%2026-02-28
BlackRock Health Sciences Term Trustfund0.73%$0.00B-33.26%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.49%$0.00B+1.57%2026-02-28
iShares Trust-iShares Micro-Cap ETFfund0.21%$0.00B-1.31%2026-03-31
Bridgeway Funds, Inc.-Ultra-Small Company Market Fundfund0.19%$0.00B+31.09%2025-12-31
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.16%$0.00B+0.00%2026-02-28
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for TCRX.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.